PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Mayo Clinic researchers study potential new CAR-T cell therapy for multiple myeloma

2021-06-25
(Press-News.org) ROCHESTER, Minn. -- Researchers at Mayo Clinic Cancer Center are studying a potential new chimeric antigen receptor-T cell therapy (CAR-T cell therapy) treatment for multiple myeloma. Their findings were published on Friday, June 24, in The Lancet.

"CAR-T cell therapy is a type of immunotherapy that involves harnessing the power of a person's own immune system by engineering their T cells to recognize and destroy cancer cells," says Yi Lin, M.D., a Mayo Clinic hematologist and lead author of the study.

Dr. Lin says the Food and Drug Administration approved idecabtagene vicleucel, the first CAR-T cell treatment for multiple myeloma, in March. "Today, we are working toward another potential CAR-T cell treatment for multiple myeloma," says Dr. Lin.

Dr. Lin says the CARTITUDE-1 study is a registration-phase 1B/II clinical trial. The trial tested B cell maturation antigen targeting CAR-T cell therapy, ciltacabtagene autoleucel (cilta-cel), in patients with multiple myeloma who received at least three previous lines of therapy with standard drugs, including proteasome inhibitors, immunomodulatory drugs and CD38 antibodies.

"Cilta-cel is made from patient's own T cells that have been genetically engineered and administered as a single dose infusion," says Dr. Lin.

Dr. Lin says the overall response rate to the treatment was 97%, while the complete response rate and progression-free survival rates were 67% and 77%, respectively. The overall survival rate was 89%.

"Updates on this study were also recently presented at the American Society of Clinical Oncology annual meeting, which occurred after our paper was accepted for publication in The Lancet," says Dr. Lin. "Our ASCO presentation showed a continued deepening response for patients receiving this therapy, with a complete response rate of 80%," says Dr. Lin. "These are very impressive results for myeloma patients who have already gone through many lines of therapy for their disease."

Going forward, Dr. Lin says it will be important to better understand the clinical features of patients who have experienced durable remissions on this therapy and the mechanisms behind patients who relapse.

"While comparisons cannot be formally made across two separate single-arm studies of ide-cel and cilta-cel, the impressive high response rate and progression-free survival of patients treated with cilta-cel are very exciting," says Dr. Lin.

She cautions, however, that the potential translation of this research into a clinical individualized therapy will require solving many logistical details, including ensuring that the transition from manufacturing for research to a commercial product remains reliable.

INFORMATION:

About Mayo Clinic Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news. For information on COVID-19, including Mayo Clinic's Coronavirus Map tracking tool, which has 14-day forecasting on COVID-19 trends, visit the Mayo Clinic COVID-19 Resource Center.

Media contact: Joe Dangor, Mayo Clinic Public Affairs, 507-284-5005, newsbureau@mayo.edu



ELSE PRESS RELEASES FROM THIS DATE:

Backscatter breakthrough runs near-zero-power IoT communicators at 5G speeds everywhere

Backscatter breakthrough runs near-zero-power IoT communicators at 5G speeds everywhere
2021-06-25
The promise of 5G Internet of Things (IoT) networks requires more scalable and robust communication systems -- ones that deliver drastically higher data rates and lower power consumption per device. Backscatter radios ? passive sensors that reflect rather than radiate energy ? are known for their low-cost, low-complexity, and battery-free operation, making them a potential key enabler of this future although they typically feature low data rates and their performance strongly depends on the surrounding environment. Researchers at the Georgia Institute of Technology, Nokia Bell Labs, and Heriot-Watt University have found a low-cost way for backscatter radios to support high-throughput communication and 5G-speed Gb/sec data transfer using only a single transistor when previously ...

Optical tweezer technology tweaked to overcome dangers of heat

Optical tweezer technology tweaked to overcome dangers of heat
2021-06-25
Three years ago, Arthur Ashkin won the Nobel Prize for inventing optical tweezers, which use light in the form of a high-powered laser beam to capture and manipulate particles. Despite being created decades ago, optical tweezers still lead to major breakthroughs and are widely used today to study biological systems. However, optical tweezers do have flaws. The prolonged interaction with the laser beam can alter molecules and particles or damage them with excessive heat. Researchers at The University of Texas at Austin have created a new version of optical tweezer technology that fixes this problem, a development ...

Unbroken: New soft electronics don't break, even when punctured

Unbroken: New soft electronics dont break, even when punctured
2021-06-25
Want a smartphone that stretches, takes damage, and still doesn't miss a call? A team of Virginia Tech researchers from the Department of Mechanical Engineering and the Macromolecules Innovation Institute has created a new type of soft electronics, paving the way for devices that are self-healing, reconfigurable, and recyclable. These skin-like circuits are soft and stretchy, sustain numerous damage events under load without losing electrical conductivity, and can be recycled to generate new circuits at the end of a product's life. Led by Assistant Professor Michael Bartlett, the team recently published its findings in END ...

NUST MISIS scientists create unique alloy for air, rail transports

NUST MISIS scientists create unique alloy for air, rail transports
2021-06-25
Scientists from the National University of Science and Technology "MISIS" (NUST MISIS) in cooperation with their colleagues from the Siberian Federal University and the Research and Production Centre of Magnetic Hydrodynamics (Krasnoyarsk) have developed a technology for producing a unique heat-resistant aluminium alloy with improved durability. According to the researchers, this new alloy could replace more expensive and heavier copper conductors in aircraft and high-speed rail transport. The study results were published in an interdisciplinary, peer-reviewed journal, the Materials Letters. (https://www.sciencedirect.com/science/article/abs/pii/S0167577X2100896X) Researchers have created a method for producing ...

More intense predation in the tropics can limit marine invasions

2021-06-25
Night and day, oil tankers, yachts and cargo ships stacked with shipping containers ply the 80-kilometer (50-mile) waterway through the jungles of Panama between the Atlantic and the Pacific Ocean: about 40 ships every 24 hours. But even though the Canal is fed by freshwater rivers that empty through the locks on each end, a system that generally prevents fish and smaller marine invertebrates from hopping from ocean to ocean, some still manage to get through, clinging to the hulls of ships. Other invading species arrive from far-flung ports, dumped with ballast water as ships prepare for transit. "Panama is a major shipping hub that provides amazing opportunities to test key ideas about marine invasions by studying ...

Inflatable, shape-changing spinal implants could help treat severe pain

2021-06-25
A team of engineers and clinicians has developed an ultra-thin, inflatable device that can be used to treat the most severe forms of pain without the need for invasive surgery. The device, developed by researchers at the University of Cambridge, uses a combination of soft robotic fabrication techniques, ultra-thin electronics and microfluidics. The device is so thin - about the width of a human hair - that it can be rolled up into a tiny cylinder, inserted into a needle, and implanted into the epidural space of the spinal column, the same area ...

Nanotech OLED electrode liberates 20% more light, could slash display power consumption

2021-06-25
A new electrode that could free up 20% more light from organic light-emitting diodes has been developed at the University of Michigan. It could help extend the battery life of smartphones and laptops, or make next-gen televisions and displays much more energy efficient. The approach prevents light from being trapped in the light-emitting part of an OLED, enabling OLEDs to maintain brightness while using less power. In addition, the electrode is easy to fit into existing processes for making OLED displays and light fixtures. "With our approach, you can do it all in ...

Researchers give yeast a boost to make biofuels from discarded plant matter

Researchers give yeast a boost to make biofuels from discarded plant matter
2021-06-25
More corn is grown in the United States than any other crop, but we only use a small part of the plant for food and fuel production; once people have harvested the kernels, the inedible leaves, stalks and cobs are left over. If this plant matter, called corn stover, could be efficiently fermented into ethanol the way corn kernels are, stover could be a large-scale, renewable source of fuel. "Stover is produced in huge amounts, on the scale of petroleum," said Whitehead Institute Member and Massachusetts Institute of Technology (MIT) biology professor Gerald Fink. "But there are enormous technical challenges to using them cheaply to create biofuels and other important chemicals." And so, year after year, most of the woody corn material is left in the fields to rot. Now, a ...

Test distinguishes SARS-CoV-2 from other coronaviruses with 100% accuracy

Test distinguishes SARS-CoV-2 from other coronaviruses with 100% accuracy
2021-06-25
DURHAM, N.C. - Biomedical engineers at Duke University have demonstrated a tablet-sized device that can reliably detect multiple COVID-19 antibodies and biomarkers simultaneously. Initial results show the test can distinguish between antibodies produced in response to SARS-CoV-2 and four other coronaviruses with 100% accuracy. The researchers are now working to see if the easy-to-use, energy-independent, point-of-care device can be used to predict the severity of a COVID-19 infection or a person's immunity against variants of the virus. Having also recently shown the same "D4 assay" platform can detect Ebola infections a day earlier than the gold standard polymerase chain reaction (PCR) test, the researchers say the results show how flexible the technology can be to adapt to other ...

Engineered yeast could expand biofuels' reach

2021-06-25
CAMBRIDGE, MA - Boosting production of biofuels such as ethanol could be an important step toward reducing global consumption of fossil fuels. However, ethanol production is limited in large part by its reliance on corn, which isn't grown in large enough quantities to make up a significant portion of U.S. fuel needs. To try to expand biofuels' potential impact, a team of MIT engineers has now found a way to expand the use of a wider range of nonfood feedstocks to produce such fuels. At the moment, feedstocks such as straw and woody plants are difficult to use for biofuel production because they first need to be broken down to fermentable sugars, a process that releases numerous byproducts that are toxic to yeast, the microbes most commonly used to produce biofuels. The ...

LAST 30 PRESS RELEASES:

Low-dose ketamine shows promise for pain relief in emergency department patients

Lifestyle & risk factor changes improved AFib symptoms, not burden, over standard care

Researchers discover new cognitive blueprint for making and breaking habits

In a small international trial, novel oral medication muvalaplin lowered Lp(a)

Eradivir’s EV25 therapeutic proven to reduce advanced-stage influenza viral loads faster, more thoroughly in preclinical studies than current therapies

Most Medicare beneficiaries do not compare prescription drug plans – and may be sticking with bad plans

“What Would They Say?” video wins second place in international award for tobacco control advocacy

Black Britons from top backgrounds up to three times more likely to be downwardly mobile

Developing an antibody to combat age-related muscle atrophy

Brain aging and Alzheimer's: Insights from non-human primates

Can cells ‘learn’ like brains?

How cells get used to the familiar

Seemingly “broken” genes in coronaviruses may be essential for viral survival

Improving hurricane modeling with physics-informed machine learning

Seed slippage: Champati cha-cha

Hospitalization following outpatient diagnosis of RSV in adults

Beyond backlash: how feeling threatened by diversity can trigger positive change

Climate change exposure associated with increased emergency imaging

Incorrect AI advice influences diagnostic decisions

Building roots in glass, a bio-inspired approach to creating 3D microvascular networks using plants and fungi

Spinning fusion fuel for efficiency

The American Pediatric Society names Dr. Beth Tarini as the recipient of the 2025 Norman J. Siegel New Member Outstanding Science Award

New Clinical Study Confirms the Anti-Obesity Effects of Kimchi

Highly selective pathway for propyne semihydrogenation achieved via CoSb intermetallic catalyst

GERD linked to cardiovascular risk factors: New insights from Mendelian randomization study

Content moderators are influenced by online misinformation

Adulting, nerdiness and the importance of single-panel comics

Study helps explain how children learned for 99% of human history

The impact of misinformation on Spanish-language social media platforms

Populations overheat as major cities fail canopy goals: new research

[Press-News.org] Mayo Clinic researchers study potential new CAR-T cell therapy for multiple myeloma